Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2930 (LINC02930) is a presumed non-coding transcript annotated in the human genome as a lincRNA, meaning it is a long RNA molecule that does not code for protein and does not overlap any known protein-coding gene. LincRNAs, as a class, are involved in a variety of cellular processes, such as chromatin remodeling, transcriptional regulation, and control of gene expression through both sequence-dependent and sequence-independent mechanisms. Many lincRNAs remain poorly characterized, with unknown biological functions and clinical relevance, and most have not been experimentally validated as involved in disease processes or as therapeutic targets. No information is currently available suggesting LINC02930 has any specific biological function, disease involvement, or drug interactions. It is likely an uncharacterized member of the general lincRNA population, and may be listed purely based on genomic annotation methods without experimental confirmation of functional importance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2930 (LINC02930).